For the Inventor, By the Inventor

Enter assignee name

Billerica, MA, United States of America

Emd Lexigen Research Center Corp.

USPTO Granted Patents = 15

% Expired Patents = 33.3

CIPO Patents = 1

Forward Citations = 756

Loading Chart...

Loading Chart...

13 inventors (with patents filed for the assignee):

Stephen D Gillies (15 out of 74 patents)

Kin-Ming Lo (9 out of 40 patents)

David A Cheresh (3 out of 28 patents)

4. Ralph A Reisfeld (3 out of 17 patents)

5. Holger N Lode (3 out of 4 patents)

6. Susan Xiuqi Qian (2 out of 13 patents)

7. Yan Lan (2 out of 6 patents)

8. Pascal Andre Stein (1 out of 7 patents)

9. Christa Burger (1 out of 8 patents)

10. Scott Lauder (1 out of 4 patents)

11. John S Wesolowski, Jr (1 out of 3 patents)

12. Kin Ming Lo (1 out of 1 patent)

13. Anita Anne Hamilton (1 out of 19 patents)

14. Yan Lan (0 patent)

15 patents: Sort by Forward Citations

1. 7833976 - Methods for treatment of tumors and metastases using a combination of anti-angiogenic and immuno therapies (2010-11-16),

2. 7365054 - Methods for treatment of tumors and metastases using a combination of anti-angiogenic and immuno therapies (2008-04-29),

3. 7323549 - IL-7 fusion proteins (2008-01-29),

4. 7226998 - Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation (2007-06-05),

5. 7186804 - IL-2 fusion proteins with modulated selectivity (2007-03-06),

6. 7169904 - Immunocytokine sequences and uses thereof (2007-01-30),

7. 7148321 - Expression technology for proteins containing a hybrid isotype antibody moiety (2006-12-12),

8. 7141651 - Multiple cytokine protein complexes (2006-11-28),

9. 7115261 - Methods for treatment of tumors and metastases using a combination of anti-angiogenic and immuno therapies (2006-10-03),

10. 7091321 - Enhancing the circulating half-life of antibody-based fusion proteins (2006-08-15),

11. 7067110 - Fc fusion proteins for enhancing the immunogenicity of protein and peptide antigens (2006-06-27),

12. 6992174 - Reducing the immunogenicity of fusion proteins (2006-01-31),

13. 6969517 - Recombinant tumor specific antibody and use thereof (2005-11-29),

14. 6838260 - Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation (2005-01-04),

15. 6617135 - Multiple cytokine protein complexes (2003-09-09),

Company Overview

Emd Lexigen Research Center Corp., based in Billerica, MA, specializes in advanced biopharmaceutical research and development. The organization focuses on innovative solutions in the fields of genomics, molecular biology, and therapeutic development, aiming to address complex health challenges. With a commitment to scientific excellence, Emd Lexigen collaborates with various stakeholders to drive breakthroughs in precision medicine and enhance patient outcomes through cutting-edge technologies and methodologies.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

15 Patents

#41 in Billerica, MA

#1,276 in Massachusetts

#21,068 in US

#39,959 in the World

Billerica, MA, United States of America

Emd Lexigen Research Center Corp.

Forward Citations = 756

13 inventors:

Stephen D Gillies (15 out of 74 patents)

Kin-Ming Lo (9 out of 40 patents)

David A Cheresh (3 out of 28 patents)

4. Ralph A Reisfeld (3 out of 17 patents)

5. Holger N Lode (3 out of 4 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Emd Lexigen Research Center Corp.. Retrieved from https://idiyas.com/company/emd-lexigen-research-center

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…